|Mid Price||GBX 220.00||Day Change||GBX -0.90 (-0.41%)|
|Price Date||15 Feb 2019||Crown Rating|
|Shares Class||Acc.||Yield||1.07 %|
|Last Ex-Dividend Date||01 March 2018||Dividend Frequency||Annually|
|Sector||UK All Companies||Fund Size||192,300,000.00|
|Launch Date||06/03/2009||Standard Initial Charge||4.00%|
|Ongoing cost||1.40%||Annual Management Charge||1.35%|
The fund aims to provide long term capital growth by investing in UK equities. The fund is primarily invested in 'recovery' shares listed on the UK stock market and these will generally be companies of a large and medium size. The fund is actively managed by our investment team who will select stocks to try to take advantage of the opportunities they have identified. Past performance is not a guide to future returns and future returns are not guaranteed. The price of assets and the income from them may go down as well as up and cannot be guaranteed; an investor may receive back less than their original investment. The fund may use derivatives to reduce risk or cost, or to generate additional capital or income at low risk. Usage of derivatives is monitored to ensure that the fund is not exposed to excessive or unintended risks. The value of assets held within the fund may rise and fall as a result of exchange rate fluctuations.
Andrew is responsible for the management of the UK Equity Recovery Fund, as well as analysing the Mining, Food & Drug Retailers, Non-Life Insurance and Pubs sectors. Andrew joined the UK Equity Team of Standard Life Investments (now Aberdeen Standard Investments) in June 2016 as Investment Director. Andrew joined from Baillie Gifford, where he worked for ten years as Investment Analyst and subsequently Investment Manager, with experience of global, UK and European equities, as well as credit. BA (1st Class Honours) in Law from Girton College, University of Cambridge.